Study in Healthy Subjects to Determine the Effect of an Inhibitor on Exposure to Relacorilant and Its Metabolites
Clinical trial NCT03512548 · COMPLETED
Trial details
- NCT number
- NCT03512548
- Sponsor
- Corcept Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-10
- Primary completion
- 2019-07-29
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.